CRISPR Therapeutics AG

NASDAQ: CRSP · Real-Time Price · USD
59.75
0.93 (1.58%)
At close: Aug 15, 2025, 10:56 AM

CRISPR Therapeutics Fail-to-Deliver

Total FTD Shares
9.3K
Below Average
FTD / Avg. Volume
0.28%
Low Impact
1-Year Change
> 100%
Positive Trend

FTD Chart

As of Jul 14, 2025, CRISPR Therapeutics AG has 9,303 shares failed to deliver, representing 0.28% of the average daily volume of 3,300,427.6 shares. Over the past year, the monthly average FTD is 22,625 shares, with the current level 59% below the historical average, indicating low settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.

FTD History

Date Price FTD Shares % Change
Jul 14, 2025 56.42 9.3K -98.87%
Jun 30, 2025 48.64 823.53K +281930.14%
May 30, 2025 36.29 292 -99.25%
Apr 30, 2025 38.67 38.97K +59.84%
Mar 31, 2025 34.03 24.38K +78535.48%
Feb 27, 2025 43.62 31 -98.63%
Jan 31, 2025 41.59 2.26K -50.12%
Dec 27, 2024 40.02 4.53K +408.65%
Nov 29, 2024 51.17 890 -97.86%
Oct 31, 2024 46.39 41.6K +18471.43%
Sep 30, 2024 46.98 224 -99.47%
Aug 30, 2024 47.72 42.2K +769.68%
Jul 30, 2024 56.41 4.85K +2641.24%
Jun 28, 2024 54.01 177 +268.75%
May 31, 2024 53.74 48 -99.93%
Apr 25, 2024 53.73 70.03K +2650.51%
Mar 27, 2024 70.16 2.55K +8112.90%
Feb 29, 2024 84.22 31 -98.75%
Jan 30, 2024 64.48 2.48K -66.38%
Dec 28, 2023 64.3 7.38K +746.96%
Nov 29, 2023 69.09 871 -57.64%
Oct 27, 2023 38.74 2.06K -96.42%
Sep 29, 2023 45.39 57.44K +20636.46%
Aug 11, 2023 49.65 277 -22.84%
Jul 31, 2023 57.33 359 -78.45%
Jun 28, 2023 57.16 1.67K +880.00%
May 31, 2023 64.04 170 +91.01%
Apr 28, 2023 48.94 89 -98.29%
Mar 31, 2023 45.23 5.21K -90.09%
Feb 28, 2023 49.32 52.55K +20110.38%
Jan 30, 2023 49.96 260 n/a